Related Experiment Video
Updated: Aug 3, 2026
09:44
Oral Biofilm Analysis of Palatal Expanders by Fluorescence In-Situ Hybridization and Confocal Laser Scanning Microscopy
Published on: October 20, 2011
Time-resolved autofluorescence spectroscopy for classifying normal and premalignant oral tissues
Hsin-Ming Chen1, Chun-Pin Chiang, Chun You
1Department of Dentistry, National Taiwan University Hospital, Taiwan.
Lasers in Surgery and Medicine
|June 15, 2005
Summary
Time-resolved autofluorescence spectroscopy effectively distinguishes normal oral tissue from premalignant lesions. This technique shows high accuracy in identifying oral dysplasia and other lesions, aiding in early diagnosis.
Area of Science:
- Biomedical Optics
- Medical Spectroscopy
- Oral Pathology
Background:
- Time-resolved autofluorescence spectroscopy is established for differentiating normal tissues from precancerous and cancerous tissues.
- Oral premalignant lesions require accurate diagnostic methods for timely intervention.
Purpose of the Study:
- To evaluate the potential of time-resolved autofluorescence spectroscopy in distinguishing normal oral mucosa (NOM) from oral premalignant lesions.
- Specifically differentiating verrucous hyperplasia (VH), epithelial hyperplasia (EH), and epithelial dysplasia (ED) from NOM.
Main Methods:
- Collected time-resolved autofluorescence spectra (633 nm excitation, 410 nm excitation) from 76 oral tissue samples (15 VH, 9 EH, 14 ED, 38 NOM).
- Calculated two-component fluorescence lifetimes for each sample.
- Applied Fisher's discriminant analysis (FDA) for classification and differentiation.
Main Results:
- FDA successfully separated the 76 oral tissue samples into three distinct groups.
- Achieved high diagnostic accuracy: 93% for ED, 75% for VH and EH, and 100% for NOM using a leave-one-out method.
- Demonstrated that FDA could effectively distinguish all oral premalignant lesions (VH, EH, ED) from NOM.
Conclusions:
- Time-resolved autofluorescence spectroscopy, utilizing two-component lifetime analysis and FDA, is a highly sensitive method for in vivo diagnosis of oral premalignant lesions.
- This spectroscopic approach offers a promising tool for early detection and management of oral precancerous conditions.
